CENTERSPACE — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CENTERSPACE filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.66M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $260.98M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $261.31M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $256.72M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $201.71M | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $45.54M | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | $44.14M | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | $43.91M | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | $44.41M | Feb 22, 2021 |
| FY2019 | Dec 31, 2019 | $30.29M | Feb 19, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.10M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | ($11.33M) | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $41.33M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | ($14.11M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($29.0K) | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | ($4.38M) | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | $19.63M | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | ($3.80M) | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | ($7.01M) | Feb 22, 2021 |
| FY2019 | Dec 31, 2019 | ($2.76M) | Feb 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.54M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $20.48M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $84.45M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $13.86M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $29.89M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $33.84M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $109.04M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $5.09M | Feb 22, 2021 |
| FY2020 | Apr 30, 2018 | ($23.70M) | Feb 22, 2021 |
| FY2019 | Apr 30, 2017 | ($30.11M) | Feb 19, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.93B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $1.91B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.93B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.03B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.94B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.46B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.39B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $1.34B | Feb 19, 2020 |
| FY2019 | Apr 30, 2018 | $1.43B | Feb 19, 2020 |
| FY2018 | Apr 30, 2017 | $1.47B | Jun 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $1.01B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $978.78M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.07B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $918.45M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $774.80M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $695.96M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $686.58M | Feb 19, 2020 |
| FY2019 | Apr 30, 2018 | $732.45M | Feb 19, 2020 |
| FY2018 | Apr 30, 2017 | $831.24M | Jun 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $719.16M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $751.99M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $709.83M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $729.54M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $772.03M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $618.21M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $619.05M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $568.79M | Feb 19, 2020 |
| FY2019 | Apr 30, 2018 | $605.66M | Feb 19, 2020 |
| FY2018 | Apr 30, 2017 | $560.94M | Jun 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 3 | Feb 22, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 3 | Feb 22, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.83M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $12.03M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $8.63M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $10.46M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $31.27M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $392.0K | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $26.58M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $13.79M | Feb 22, 2021 |
| FY2020 | Apr 30, 2018 | $11.89M | Feb 22, 2021 |
| FY2018 | Apr 30, 2017 | $28.82M | Jun 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $955.39M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $916.02M | Feb 18, 2025 |
| FY2022 | Dec 31, 2022 | $1.01B | Feb 21, 2023 |
| FY2021 | Dec 31, 2021 | $859.78M | Feb 28, 2022 |
| FY2018 | Apr 30, 2018 | $509.92M | Jun 28, 2018 |
| FY2018 | Apr 30, 2017 | $565.98M | Jun 28, 2018 |
| FY2017 | Apr 30, 2016 | $812.39M | Jun 28, 2017 |
| FY2016 | Apr 30, 2015 | $596.97M | Jun 29, 2016 |
| FY2015 | Apr 30, 2014 | $997.69M | Jun 29, 2015 |